Novo Nordisk is not wasting time beginning the layoffs that it announced last week as part of a major restructuring effort.

X4 Pharmaceuticals is again shrinking its workforce, this time by 50% as the company pushes to save costs and finish a phase ...

SK Biopharmaceutical’s Xcopri (cenobamate) met the bar in a phase 3 trial that could support the company’s ambitions of ...

Saphnelo, which generated $304 million in sales in the first half of this year, is projected to achieve peak annual sales of ...

That’s according to Will Reese, chief innovation officer at Inizio Evoke, who spoke with Fierce Pharma Marketing during last ...

Merck & Co. is stepping up to the plate to raise awareness of the dangers of high LDL cholesterol and how it can increase the risk of atherosclerotic cardiovascular disease (ASCVD). | Merck is ...

The marketing-related warning letters uploaded Tuesday number nearly 70, though the majority target online pharmacies and ...

More than 40 years after establishing the first U.S. pharmaceutical joint venture in China, Bristol Myers Squibb is handing ...

The U.S. regulator has signed off on Corstasis Therapeutics’ Enbumyst to relieve the edema associated with congestive heart ...

A pre-approval inspection by the FDA of Dr. Reddy’s Bachupally biologics production facility earlier this month resulted in ...

Secretary Robert F. Kennedy Jr. | After HHS secretary Robert F. Kennedy Jr. overhauled the CDC's vaccine advisory panel over ...

British Big Pharma GSK is welcoming President Donald Trump to the U.K. with a hefty gift: a five-year, $30 billion planned investment in U.S. R&D and manufacturing. | British Big Pharma GSK is ...